Skip to Main Content

Author Details

Jeffrey Parsonnet
1974
57
28
PMIDPaper TitleJournal TitlePublished Year
35325084Frequency and Geographic Distribution of Borrelia miyamotoi, Borrelia burgdorferi, and Babesia microti Infections in New England Residents.Clinical Infectious Diseases2022
34105984Clinical Decision Support Trees Can Help Optimize Utilization of Anaplasma phagocytophilum Nucleic Acid Amplification Testing.Journal of Clinical Microbiology2021
289193792017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.Heart Rhythm2017
23640863Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.Toxicological Sciences2013
20504239Final report of the Lyme disease review panel of the Infectious Diseases Society of America.Clinical Infectious Diseases2010
20731864Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women.BMC Infect Dis2010
21051598The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.Science2010
20007392Outbreak of skin infections in college football team members due to an unusual strain of community-acquired methicillin-susceptible Staphylococcus aureus.Journal of Clinical Microbiology2010
19863451To build a better mousetrap: pitfalls on the path to improving tampon safety.Clinical Infectious Diseases2009
18215708Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B.Am J Kidney Dis2008
18550735Prevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women.Journal of Clinical Microbiology2008
17340193Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndrome.Journal of Clinical Immunology2007
16914701Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.N Engl J Med2006
16145118Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.J Clin Microbiol2005
12793887Severe sepsis: variation in resource and therapeutic modality use among academic centers.Crit Care2003
12558238Resource utilization among patients with sepsis syndrome.Infect Control Hosp Epidemiol2003
14668609Relationship of pulmonary artery catheter use to mortality and resource utilization in patients with severe sepsis.Crit Care Med2003
11317249Recurrent nonmenstrual toxic shock syndrome: clinical manifestations, diagnosis, and treatment.Clinical Infectious Diseases2001
9770160Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group.Clin Infect Dis1998
9218672Epidemiology of sepsis syndrome in 8 academic medical centers.JAMA1997
9395366Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group.J Infect Dis1997
8537689Effect of tampon composition on production of toxic shock syndrome toxin-1 by Staphylococcus aureus in vitro.Journal of Infectious Diseases1996
8714246Nonmenstrual toxic shock syndrome: new insights into diagnosis, pathogenesis, and treatment.Current Clinical Topics in Infectious Diseases1996
8001394Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats.Crit Care Med1995
7664553Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.Critical Care Medicine1995
8011830Bacterial laryngotracheitis associated with toxic shock syndrome in an adult.Clinical Infectious Diseases1994
8045139Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits.Critical Care Medicine1994
8013061Efficacy of a recombinant endotoxin neutralizing protein in rabbits with Escherichia coli sepsis.1994
8503792Another case of polymyositis after ciguatera toxin exposure.1993
8286654Azathioprine hypersensitivity mimicking sepsis in a patient with Crohn's disease.Clinical Infectious Diseases1993
1538154Limulus antilipopolysaccharide factor protects rabbits from meningococcal endotoxin shock.Journal of Infectious Diseases1992
1597037Effect of a human immunoglobulin preparation for intravenous use in a rabbit model of meningococcal endotoxin-induced shock.Critical Care Medicine1992
1582001Effect of meningococcal endotoxin in a rabbit model of shock.1992
1898267Polymyositis after ciguatera toxin exposure.1991
1908001Effect of polymyxin B on experimental shock from meningococcal and Escherichia coli endotoxins.Journal of Infectious Diseases1991
2279990Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus.Journal of Clinical Microbiology1990
2542966Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.Proceedings of the National Academy of Sciences of the United States of America1989
2648540Mediators in the pathogenesis of toxic shock syndrome: overview.1989
2928650Effects of monoclonal antibody on biologic function of toxic shock syndrome toxin 1 in vitro and in vivo.1989
2808668Phosphatidylinositol-specific phospholipase C, a possible virulence factor of Staphylococcus aureus.Journal of Clinical Microbiology1989
2830336Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells.Journal of Immunology1988
3198939Structure-activity relationship of toxic-shock-syndrome toxin-1: derivation and characterization of immunologically and biologically active fragments.Journal of Infectious Diseases1988
3134495Effect of magnesium on production of toxic-shock-syndrome toxin-1: a collaborative study.Journal of Infectious Diseases1988
3263447Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin-1.Journal of Infectious Diseases1988
3257201Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo.Infection and Immunity1988
3102633Interaction of magnesium ion, oxygen tension, and temperature in the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus.Journal of Infectious Diseases1987
3624436Nonproduction of toxic shock syndrome toxin 1 by coagulase-negative staphylococci.Journal of Clinical Microbiology1987
3317745On the pathogenesis of toxic shock syndrome.1987
3137706Role of magnesium ion in the pathogenesis of toxic shock syndrome.1987
3570455A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1.Infection and Immunity1987
  • 1 - 50 of 57

Recommended Authors

Collaborators

Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 6
Brigham and Women's Hospital Division of General Internal Medicine
Co-authored papers 6
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 3
Ragon Institute of MGH
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Genentech Inc.
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Frederick National Laboratory for Cancer Research, National Cancer Institute
Co-authored papers 1
Co-authored papers 1